Aberrant Trans- and De- Nitrosylation Underpins Nitrosative Stress in Cardiometabolic HFpEF
Abstract Body: Background: Heart failure with preserved ejection fraction (HFpEF) is among the leading causes of cardiovascular mortality and morbidity. Recent reports suggest excessive myocardial protein S-nitrosylation (-SNO), a hallmark of nitrosative stress, contributes to HFpEF pathophysiology. However, the role of transnitrosylases, enzymes that induce protein-SNO, or denitrosylases, enzymes that eliminate protein-SNO, have not been investigated in the context of HFpEF.
Research Questions and Goals: We sought to investigate the regulation of protein nitrosylation dynamics in a rat model of cardiometabolic HFpEF.
Methods: Echocardiographic assessment, invasive hemodynamic measurements, and exercise testing were conducted in WKY or ZSF1 obese (Ob) rats to evaluate HFpEF severity. Nitric oxide (NO) bioavailability and protein-SNO levels were determined in the heart tissue. Endothelial-dependent vascular reactivity was assayed to further evaluate NO signaling. In parallel, single-cell (sc) RNA sequencing was performed to determine the transcriptional changes in trans- and denitrosylases, as well as NO synthases.
Results: We observed progressive deterioration in LV diastolic function (significantly elevated E/e’ and LV end-diastolic pressure) and exercise performance in ZSF1 Ob when compared to WKY controls. Notably, ZSF1 Ob rats exhibited an age-dependent elevation in protein-SNO levels, despite significant reduction in NO bioavailability and signaling. Targeted sc transcriptomic analysis revealed significantly elevated expression of transnitrosylases such as hemoglobin subunit α and β in cardiomyocytes, endothelial cells, and cardiac fibroblasts from ZSF1 Ob hearts. In contrast, significantly reduced expression of denitrosylases such as thioredoxin 2 was found in the ZSF1 Ob cardiomyocytes. No change was observed in expression of NO synthases (nNOS, iNOS, eNOS).
Conclusion: Herein, we demonstrate a profound disconnect between insufficient NO bioavailability and nitrosative stress in ZSF1 Ob rat model of HFpEF. Our data suggests the pathological accumulation of nitroso - proteins, may be attributed in part to the derangement of transnitrosylases and denitrosylases expression. Restoration of physiological protein nitrosylation dynamics may represent a novel therapeutic approach for HFpEF, and warrants further investigation.
Li, Zhen
( Cedars-Sinai Medical Center
, Los Angeles
, California
, United States
)
Borch Jensen, Martin
( Gordian Biotechnology
, SOUTH SAN FRANCISCO
, California
, United States
)
Vondriska, Thomas
( UCLA
, Los Angeles
, California
, United States
)
Lefer, David
( Cedars-Sinai Medical Center
, Los Angeles
, California
, United States
)
Gehred, Natalie
( UCLA
, Los Angeles
, California
, United States
)
Gromova, Tatiana
( UCLA
, Los Angeles
, California
, United States
)
Lapenna, Kyle
( LSU Health Sciences Center
, New Orleans
, Louisiana
, United States
)
Sharp, Thomas
( University of South Florida
, Tampa
, Florida
, United States
)
Chen, Jingshu
( Gordian Biotechnology
, SOUTH SAN FRANCISCO
, California
, United States
)
Shambhu, Smitha
( Gordian Biotechnology
, SOUTH SAN FRANCISCO
, California
, United States
)
Yu, Xiaoman
( Cedars-Sinai Medical Center
, Los Angeles
, California
, United States
)
Goodchild, Traci
( Cedars-Sinai Medical Center
, Los Angeles
, California
, United States
)
Author Disclosures:
Zhen Li:DO NOT have relevant financial relationships
| Martin Borch Jensen:No Answer
| Thomas Vondriska:No Answer
| David Lefer:DO have relevant financial relationships
;
Consultant:Gordian Biotechnology:Active (exists now)
; Consultant:Sulfagenix, Inc.:Active (exists now)
| Natalie Gehred:DO NOT have relevant financial relationships
| Tatiana Gromova:DO NOT have relevant financial relationships
| Kyle LaPenna:DO NOT have relevant financial relationships
| Thomas Sharp:DO NOT have relevant financial relationships
| Jingshu Chen:No Answer
| Smitha Shambhu:DO have relevant financial relationships
;
Employee:Gordian Biotechnology:Active (exists now)
| Xiaoman YU:DO NOT have relevant financial relationships
| Traci Goodchild:No Answer